影像组学用于肝细胞癌诊断与预后的系统综述
影像组学特征在区分肝细胞癌与其他实性病变、预测微血管侵犯、肝切除术后早期复发及局部或系统治疗预后方面显示出良好的判别性能,但纳入研究整体质量较低,在验证、分割标准化和参考标准比较方面存在不足。
要点
- 影像组学特征可辅助鉴别肝细胞癌与其他实性病变,c-statistic为0.66-0.95。
- 影像组学特征可预测微血管侵犯(c-statistic 0.76-0.92)和肝切除术后早期复发(c-statistic 0.71-0.86)。
- 纳入研究整体质量低,内部与外部验证、标准化分割及参考标准比较不足。
核心结论
- 定量图像分析作为非侵入性生物标志物在改善肝细胞癌诊断和管理方面具有前景,但需标准化协议、结局测量、算法共享及外部验证后才能广泛应用于临床。
主要发现
- 影像组学特征区分肝细胞癌与其他实性病变的c-statistic为0.66-0.95。
- 影像组学特征预测微血管侵犯的c-statistic为0.76-0.92。
- 影像组学特征预测肝切除术后早期复发的c-statistic为0.71-0.86。
- 影像组学特征预测局部或系统治疗后预后的c-statistic为0.74-0.81。
- 常见分层特征包括图像偏度分析、瘤周区域分析及动脉期图像特征提取。
关键数值与推荐
- 诊断与预后影像组学工具常见分层特征包括图像偏度分析、瘤周区域分析和动脉期特征提取。
- 纳入研究整体质量低,常见缺陷为内部和外部验证不足、标准化图像分割缺乏及缺乏与参考标准的比较。
临床怎么用
- 影像组学作为非侵入性生物标志物有望改善肝细胞癌诊断与管理,但当前证据质量低,尚需标准化和外部验证后方可临床推广。
局限性
- 纳入研究整体质量低,常见缺陷包括内部和外部验证不足、标准化图像分割缺乏及缺乏与参考标准的比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Advances in imaging technology have the potential to transform the early diagnosis and treatment of hepatocellular carcinoma (HCC) through quantitative image analysis. Computational "radiomic" techniques extract biomarker information from images which can be used to improve diagnosis and predict tumour biology. AIMS: To perform a systematic review on radiomic features in HCC diagnosis and prognosis, with a focus on reporting metrics and methodologic standardisation. METHODS: We performed a systematic review of all full-text articles published from inception through December 1, 2019. Standardised data extraction and quality assessment metrics were applied to all studies. RESULTS: A total of 54 studies were included for analysis. Radiomic features demonstrated good discriminatory performance to differentiate HCC from other solid lesions (c-statistics 0.66-0.95), and to predict microvascular invasion (c-statistic 0.76-0.92), early recurrence after hepatectomy (c-statistics 0.71-0.86), and prognosis after locoregional or systemic therapies (c-statistics 0.74-0.81). Common stratifying features for diagnostic and prognostic radiomic tools included analyses of imaging skewness, analysis of the peritumoural region, and feature extraction from the arterial imaging phase. The overall quality of the included studies was low, with common deficiencies in both internal and external validation, standardised imaging segmentation, and lack of comparison to a gold standard. CONCLUSIONS: Quantitative image analysis demonstrates promise as a non-invasive biomarker to improve HCC diagnosis and management. However, standardisation of protocols and outcome measurement, sharing of algorithms and analytic methods, and external validation are necessary prior to widespread application of radiomics to HCC diagnosis and prognosis in clinical practice.
引用
- Harding-Theobald E, Louissaint J, Maraj B, et al. Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma. Aliment Pharmacol Ther. 2021. PMID: 34390014. doi:10.1111/apt.16563
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。